The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance

Samankaltaisia teoksia

• Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)
  Tekijä: Pesta, Dominik H., et al.
  Julkaistu: (2015)
• Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice
  Tekijä: Sebastian Brachs, et al.
  Julkaistu: (2016-11-01)
• Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice
  Tekijä: Brachs, Sebastian, et al.
  Julkaistu: (2016)
• The longevity gene mIndy (I’m Not Dead, Yet) affects blood pressure through sympathoadrenal mechanisms
  Tekijä: Willmes, Diana M., et al.
  Julkaistu: (2021)
• THE ROLE OF INDY IN METABOLIC REGULATION
  Tekijä: Diana M Willmes, et al.
  Julkaistu: (2013-03-01)